Description
An inhibitor of DNA methyltransferases that reduces hypermethylation associated with certain diseases, including myelodysplastic syndromes (IC50s = 2.4 and 2.6 μM for in vitro anti-myeloma activity) and cancer (IC50s ~ 0.4 μM for inhibiting proliferation of various cancer cell lines)
Formal name: 4-amino-1-β-D-ribofuranosyl-1,3,5-triazin-2(1H)-one
Synonyms: 5-AzaC|Antibiotic U 18496|Ladakamycin|Mylosar|NSC 102816|NSC 103-627|U 18496|WR 183027
Molecular weight: 244.2
CAS: 320-67-2
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Demethylases||Research Area|Epigenetics, Transcription, & Translation|Writers|DNA/RNA Methylation